Together, these observations identify PCSK9 as a mechanistic link between systemic metabolic state and peripheral nerve integrity, and they highlight the need for targeted studies of PCSK9 in neuropathies associated with diabetes, obesity, and dyslipidemia. Here, PCSK9 is linked to obesity due to melanocortin 4 receptor deficiency.